BIOGEN INC. — Investor Relations & Filings
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| ARS | 2026-04-28 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46003499 | 8-K | 2026-05-14 | English | ||
| 46147249 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46147251 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 38512550 | 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 38494955 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 46147256 | ARS | 2026-04-28 | English | ||
| 46147325 | DEFA14A | 2026-04-28 | English | ||
| 46147321 | DEF 14A | 2026-04-28 | English | ||
| 46147329 | Major Shareholding Notification 2026 | 2026-04-07 | English | ||
| 33590958 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-06 | English | ||
| 33122713 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-03-31 | English | ||
| 33052213 | SCHEDULE 13G/A - BIOGEN INC. (0000875045) (Subject) | 2026-03-26 | English | ||
| 46147335 | CURRENT REPORT | 2026-03-11 | English | ||
| 32882744 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
| 32882743 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cellectis
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunot…
|
ALCLS | FR | Manufacturing |
|
Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectio…
|
299660 | KR | Manufacturing |
|
Cellromax Science Co., Ltd.
Researches and develops health foods, derma-cosmetics, and …
|
471820 | KR | Manufacturing |
|
CellSeed Inc.
Develops and commercializes cell sheet engineering for rege…
|
7776 | JP | Manufacturing |
|
Celltrion, Inc.
Biopharmaceutical firm developing biosimilars for autoimmun…
|
068270 | KR | Manufacturing |
|
Celltrion Pharm Inc.
Manufactures and supplies chemical pharmaceuticals and bios…
|
068760 | KR | Manufacturing |
|
CELLUMED CO., LTD.
Develops and manufactures medical devices, tissue grafts, a…
|
049180 | KR | Manufacturing |
|
Celon Pharma S.A.
An integrated pharmaceutical company researching and manufa…
|
CLN | PL | Manufacturing |
|
Celularity Inc
Develops allogeneic cell therapies and biomaterials from th…
|
CELU | US | Manufacturing |
|
Cenra Inc.
Diversified healthcare enterprise providing R&D, manufactur…
|
3716 | TW | Manufacturing |
BIOGEN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30291/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30291 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30291 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30291 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30291}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOGEN INC. (id: 30291)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.